DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Albain K, Nag S, Calderillo-Ruiz G. et al.
Global phase III study of gemcitabine plus paclitaxel (GT) versus paclitaxel (T) as frontline therapy for metastatic breast cancer (MBC): First report of overall survival (abstr 510).
Proc Am Soc Clin Oncol 2004; 22: 25-25
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.